Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00911703 · ClinicalTrials.gov registry record
Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely Sent Home (The DECIDE Study)
A clinical trial of Acute Heart Failure, sponsored by Vanderbilt University.
- Completed
- Registry status
- 835
- Enrollment target
- 2
- Study locations
NCT00911703 is a study of Acute Heart Failure that has completed, run by Vanderbilt University. The registered enrollment target is 835 participants, below the 1,348-participant average among 8 other Acute Heart Failure trials with a reported enrollment target (38% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00911703, a study of Acute Heart Failure, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 835 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine if certain findings (blood tests, symptom improvement, etc.) after acute heart failure treatment can identify a group of patients who are safe for early hospital discharge.
Conditions Studied
Study Locations (2)
Ohio
- University of Cincinnati - Cincinnati
Tennessee
- Vanderbilt University - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 835 participants |
| Start Date | 2008-08 |
| Est. Completion | 2015-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00911703
The ClinicalTrials.gov registry entry for NCT00911703 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 835 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,348-participant average among 8 other Acute Heart Failure trials with a reported enrollment target (38% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT00911703 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Tennessee.
Frequently Asked Questions
What is clinical trial NCT00911703 about?
NCT00911703 is a clinical study titled "Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely Sent Home (The DECIDE Study)". The purpose of this study is to determine if certain findings (blood tests, symptom improvement, etc.) after acute heart failure treatment can identify a group of patients who are safe for early hospital discharge.
What is the current status of trial NCT00911703?
This trial is currently completed. The enrollment target is 835 participants. The study started on 2008-08. Estimated completion is 2015-10.
What conditions does trial NCT00911703 study?
This clinical trial studies the following conditions: Acute Heart Failure.
Who is sponsoring clinical trial NCT00911703?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00911703 being conducted?
This trial has 2 study locations across Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RECRUITING · Phase 3
-
Improving Diagnostic Accuracy for Acute Heart Failure
ACTIVE NOT RECRUITING
-
Randomized Controlled Trial of urinE chemiStry Guided aCute heArt faiLure treATmEnt (ESCALATE)
ACTIVE NOT RECRUITING · Phase 2
-
Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot
COMPLETED · Phase 1
-
An Observational Study of the Functional Capacity of Heart Failure
COMPLETED · NA
-
Tezosentan in Acute Heart Failure
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.